Stock screener

SVRA

Conviction 28HealthcareScan · Thu, Sep 24, 2026
Hammer

Savara Inc (SVRA) closed at $5.08 (+1.60%) on Sep 24, 2026. Its latest daily candle is a hammer. Price is below its 50-day and below its 200-day moving average. RSI(14) 41, RS Rating 87, -26.8% from its 52-week high, -9.9% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

SVRA$5.08+1.60%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 1.59M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Savara IncPHARMACEUTICAL PREPARATIONSwww.savarapharma.com ↗
Price5.08
Change+1.60%
Gap+0.40%
Rel volume2.13×
Avg volume1.53M
Avg $ vol8.13M
SMA 205.33
SMA 505.45
SMA 2005.57
Price vs 50-6.83%
Price vs 200-8.84%
MA stackbearish
50/200 crossdeath · 9d
Supertrenddown · 5.68
RSI (14)41
MACD hist-0.02
MACD crossbear · 1d
Stoch %K / %D26 / 26
ADX (14)12
+DI / −DI13 / 27
RSI divergence—
MACD divergence—
ATR %4.55%
ADR %3.95%
52w high6.94
52w low3.37
From 52w high-26.80%
Above 52w low+50.74%
New 52w highNo
SqueezeOn · 35d
Bollinger width9.85%
%B0.02
Donchian pos25.16%
Donchian high5.66
Donchian low4.89
AVWAP (52w high)5.62
vs AVWAP high-9.62%
AVWAP (52w low)5.49
vs AVWAP low-7.40%
OBV trendDown
Chaikin MF (20)-0.10
Today vs 20d2.13×
Avg vol (14d)1.59M
Avg vol (20d)1.53M
Avg $ vol (20d)8.13M
Market cap1.04B
RS Rating87 / 99
RS 3m (vs SPY)-20.25%
RS 6m (vs SPY)-20.61%
RS line new highNo
Trend template2/8
Technical rank27.7
1 week-6.27%
1 month-9.29%
3 months-15.75%
6 months-3.79%
1 year+45.98%
YTD-9.93%
P/E-8.78
P/B7.27
P/S—
P/FCF-10.33
EPS-0.5300
Div yield0.02%
ROE-82.72%
ROA-61.85%
Debt/Eq0.21
Current10.13
EV/EBITDA-8.42
Gross margin190.26%
Net margin—
Rev growth0.00%
EPS growth-23.94%
Price target11.20
Target upside120.47%
Analyst ratingBuy
Institutional111.12%
Ent. value1.03B
Revenue0
Net income-40.23M
Gross profit2.04M
Free cash flow-101.06M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out204.93M
Employees70
ListedMon, Nov 18, 1996
Free float130.57M
Float %64.2%
Short interest41.43M
Days to cover24.3d
Short volume37.9%
Squeeze score80 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.16 vs −$0.14
Last surprise-14.3% miss
Setup gradeD
Conviction28 / 100
Pattern quality—
Tech rank27.7 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmHammer

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SVRA

All disclosures →
No recent disclosed trades by Congress in SVRA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SVRA · open-market 1 sell

InsiderSideShares
Lowrance David L
Chief Financial Officer · Common Stock · 2026-06-22
Sell394.53K
Lowrance David L
Chief Financial Officer · Stock Option (Right to Buy) · 2026-06-22
Exercise75K
Lowrance David L
Chief Financial Officer · Stock Option (Right to Buy) · 2026-06-22
Exercise129.35K
Lowrance David L
Chief Financial Officer · Stock Option (Right to Buy) · 2026-06-22
Exercise56.94K
Lowrance David L
Chief Financial Officer · Stock Option (Right to Buy) · 2026-06-22
Exercise87.65K
Lowrance David L
Chief Financial Officer · Stock Option (Right to Buy) · 2026-06-22
Exercise218.75K
Lowrance David L
Chief Financial Officer · Stock Option (Right to Buy) · 2026-06-22
Exercise12.5K
Lowrance David L
Chief Financial Officer · Common Stock · 2026-06-22
Exercise75K
Lowrance David L
Chief Financial Officer · Common Stock · 2026-06-22
Tax21.68K
Lowrance David L
Chief Financial Officer · Common Stock · 2026-06-22
Exercise129.35K

SEC filings

EDGAR filings in SVRA · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.